Efficacy of 5-and 10 Day Decitabine Schedules Not Different in Elderly Patients With AML

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2020年 / 34卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [1] Outcomes of 10-day decitabine with venetoclax for AML.
    Coltoff, Alexander
    Baratam, Praneeth
    Green, Kimberly Michelle
    Davis, James A.
    Smith, Deidra
    Gaffney, Kelly
    Dougherty, Elizabeth
    Milligan, Laura
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno de Gusmao, B.
    Esteves, I.
    Santos, F. P. S.
    Petrolli, M.
    Ferreira, F.
    Galvao, C., Jr.
    Perini, G.
    Hyppolito, J.
    Helman, R.
    Hamersclak, N.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S113 - S113
  • [3] EFFICACY OF DECITABINE IN 10-DAY REGIMEN IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY
    Moreno De Gusmao, B.
    Esteves, I.
    Petrolli, M.
    Hyppolito, J.
    Santos, F.
    Ferreira, F.
    Perini, G.
    Helman, R.
    Hamerschlak, N.
    [J]. HAEMATOLOGICA, 2015, 100 : 653 - 653
  • [4] Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS
    Huls, Gerwin
    Chitu, Dana A.
    Pabst, Thomas
    Klein, Saskia K.
    Stussi, Georg
    Griskevicius, Laimonas
    Valk, Peter J. M.
    Cloos, Jacqueline
    van de Loosdrecht, Arjan A.
    Breems, Dimitri
    van Lammeren-Venema, Danielle
    van Zeventer, Isabelle
    Boersma, Rinske
    Jongen-Lavrencic, Mojca
    Fehr, Martin
    Hoogendoorn, Mels
    Manz, Markus G.
    Sohne, Maaike
    Kooy, Rien van Marwijk
    Deeren, Dries
    van der Poel, Marjolein W. M.
    Legdeur, Marie Cecile
    Tick, Lidwine
    Chalandon, Yves
    Ammatuna, Emanuele
    Blum, Sabine
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    [J]. BLOOD ADVANCES, 2020, 4 (18) : 4267 - 4277
  • [5] Evaluation of 5-Day Vs. 10-Day Decitabine in Combination with Venetoclax in Newly Diagnosed AML Patients Ineligible for Induction Chemotherapy
    Perez, Jorge M. Ramos
    Tinajero, Jose
    Ngo, Dat
    Zhang, Jianying
    Koller, Paul B.
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Otoukesh, Salman
    Amanam, Idoroenyi
    Artz, Andrew S.
    Becker, Pamela S.
    Stewart, Forrest M.
    Smith, Eileen P.
    Curtin, Peter
    Forman, Stephen J.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    Marcucci, Guido
    Stein, Anthony S.
    Aldoss, Ibrahim
    Ball, Brian J.
    [J]. BLOOD, 2022, 140 : 9039 - 9040
  • [6] A Randomized Phase II Trial of 5-Day Versus 10-Day Schedules of Decitabine for Older Patients with Previously Untreated Acute Myeloid Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Kadia, Tapan
    Huang, Xuelin
    Daver, Naval
    DiNardo, Courtney D.
    Ferrajoli, Alessandra
    Wierda, William G.
    Estrov, Zeev
    Benton, Christopher B.
    Bose, Prithviraj
    Alvarado, Yesid
    Kornblau, Steven
    Ohanian, Maro
    Gaisor, Yvonne
    Richie, Mary Ann
    Pierce, Sherry
    Jabbour, Elias J.
    Cortes, Jorge E.
    Ravandi, Farhad
    [J]. BLOOD, 2017, 130
  • [7] Efficacy of 10-day decitabine in acute myeloid leukemia
    Bouligny, Ian M.
    Mehta, Vivek
    Isom, Scott
    Ellis, Leslie R.
    Bhave, Rupali R.
    Howard, Dianna S.
    Lyerly, Susan
    Manuel, Megan
    Dralle, Sarah
    Powell, Bayard L.
    Pardee, Timothy S.
    [J]. LEUKEMIA RESEARCH, 2021, 103
  • [8] EFFICACY AND SAFETY OF DECITABINE IN ELDERLY AML PATIENTS: A REAL LIFE MULTICENTER EXPERIENCE OF THE NETWORK RETE EMATOLOGICA LOMBARDA
    Borlenghi, E.
    Cattaneo, C.
    Bernardi, M.
    Basilico, C.
    Frachiolla, N.
    Fumagalli, M.
    Rossi, M.
    Sala, E.
    Sciume, M.
    Todisco, E.
    Petulla, M.
    Rossi, G.
    [J]. HAEMATOLOGICA, 2017, 102 : 676 - 677
  • [9] Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML
    Liu, Yuejian
    Chen, Feili
    Guo, Xutao
    Shi, Pengcheng
    Zha, Jie
    Fan, Zhiping
    Huang, Fen
    Xu, Bing
    [J]. BLOOD, 2012, 120 (21)
  • [10] COMPARATIVE EFFICACY OF HOMOHARRINGTONINE PLUS CYTARABINE AND DECITABINE IN PATIENTS WITH MDS/AML
    Xu, B.
    Liu, Y.
    Chen, F.
    Shi, P.
    Guo, X.
    Zha, J.
    Fan, Z.
    Huang, F.
    Zhou, S.
    [J]. HAEMATOLOGICA, 2013, 98 : 584 - 584
12345